Announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on the implementation results of the controlling shareholder's plan to increase the company's share holdings
Zhejiang Huahai Pharmaceutical Co., Ltd. 2023 Profit Distribution Plan Announcement
Corrective announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on the implementation results of share repurchase and share changes
Zhejiang Huahai Pharmaceutical Co., Ltd. announcement on share repurchase implementation results and share changes
Announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on shareholders' partial share pledges
Announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on the application for issuing shares to specific targets to obtain registration approval from the China Securities Regulatory Commission
Announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on the progress of repurchasing the company\'s shares through centralized bidding
Announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on the adjustment of the repurchase price of restricted shares and the repurchase and cancellation of restricted shares
Legal Opinion of Zhejiang Tianze Law Firm on Zhejiang Huahai Pharmaceutical Co., Ltd.'s 2021 Restricted Stock Incentive Plan to adjust repurchase prices and repurchase and cancel some restricted stocks
Announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on the repurchase and cancellation of restricted shares to creditors
Announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on the progress of repurchasing the company's shares through centralized bidding
Announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on the progress of repurchasing the company\'s shares through centralized bidding
Announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on the progress of repurchasing the company\'s shares through centralized bidding
Announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on the application for issuing shares to specific targets approved by the Shanghai Stock Exchange
The 2021 Restricted Stock Incentive Plan of Zhejiang Huahai Pharmaceutical Co., Ltd. was granted for the first time an indicative announcement to lift the listing and circulation of restricted shares during the period of lifting the sales restrictions
Announcement on the progress of Zhejiang Huahai Pharmaceutical Co., Ltd. on the repurchase of company shares through centralized bidding transactions
Zhejiang Huahai Pharmaceutical Co., Ltd.\'s 2021 Restricted Stock Incentive Plan reserves the first indicative announcement to lift the sales restriction period and lift the restricted stock listing and circulation
Supplemental Legal Opinion of Zhejiang Tianze Law Firm on Zhejiang Huahai Pharmaceutical Co., Ltd.\'s issuance of A-shares to specific targets (5)
Announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on Issuance of A-shares to Specific Targets, Diluted Spot Returns, and Adoptive Measures and Related Entity Commitments (Fourth Revision)
Announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on adjusting the company\'s plan to issue A-shares to specific targets
No Data